Development of pulmonary hypertension in 5 patients after pediatric living-donor liver transplantation: De novo or secondary?

Liver Transplantation

Volumn 12, Issue 5, 2006, Pages 870-875

  Shirouzu, Yasumasa ^a   Kasahara, Mureo ^a   Takada, Yasutsugu ^a   Taira, Kaoru ^a   Sakamoto, Seisuke ^a   Uryuhara, Kenji ^a   Ogawa, Kohei ^a   Doi, Hiraku ^a   Egawa, Hiroto ^a   Tanaka, Koichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HEPATITIS B ANTIBODY; LAMIVUDINE; PROSTACYCLIN; STEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; BILE DUCT ATRESIA; BILE DUCT DISEASE; CHILD; CHOLANGITIS; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FAILURE; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; MALE; PEDIATRICS; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PORTOENTEROSTOMY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REOPERATION; SPLENORENAL SHUNT; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LIVER TRANSPLANTATION; LIVING DONORS; MALE;

EID: 33646441021     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20758     Document Type: Article

References (25)

1. Whyte MK, Hughes JM, Peters AM, Ussov W, Patel S, Burroughs AK. Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. J Hepatol 1998; 29:85-93.
2. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004;363:1461-1468.
3. Budhiraja R, Hassoun PM. Portopulmonary hypertension: a tale of two circulations. Chest 2003;123:562-576.
4. International Primary Pulmonary Hypertension Study (IPPHS). Chest 1994;105:37S-41S.
5. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000;6:443-450.
6. Mandell MS, Groves BM, Duke J. Progressive plexogenic pulmonary hypertension following liver transplantation. Transplantation 1995;59:1488-1490.
7. Koneru B, Fisher A, Wilson DJ, Klein KM, dela Torre AN, Seguel J. De novo diagnosis of porto pulmonary hypertension following liver transplantation. Am J Transplant 2002; 2: 883-886.
8. Dabestani A, Mahan G, Gardin JM, Takenaka K, Burn C, Allfie A, Henry WL. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 1987;59:662-668.
9. Tanaka K. Uemoto S, Tokunaga Y, Fujita S, Sano K, Nishizawa T, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg 1993;217: 82-91.
10. Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996;61:247-252.
11. Mantz FA, Craige E. Portal axis thrombosis with spontaneous portocaval shunt and resultant cor pulmonale. AMA Arch Pathol 1951;52:91-97.
12. Kuo PC, Plotkin JS, Gaine S, Schroeder RA, Rustgi VK, Rubin LJ, Johnson LB. Portopulmonary hypertension and the liver transplant candidate. Transplantation 1999;67: 1087-1093.
13. Fallon MB. Portopulmonary hypertension: New clinical insights and more questions on pathogenesis. Hepatology 2003;37:253-255.
14. Egawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, Fujita S, et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999; 67:712-717.
15. Mal H, Burgiere O, Durand F, Fartoukh M, Cohen-Solal A, Fournier M. Pulmonary hypertension following hepatopulmonary syndrome in a patient with cirrhosis. J Hepatol 1999;31:360-364.
16. Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol 2005;39:S138-S142.
17. Hadengue A, Lebrec D, Moreau R, Sogni P, Durand F, Gaudin C, et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 1993;17:175-178.
18. Henderson JM, Mackay GJ, Hooks M, Chezmar JL, Galloway JR, Dodson TF, Kutner MH. High cardiac output of advanced liver disease persists after orthotopic liver transplantation. Hepatology 1992;15:258-262.
19. Fujimoto M, Moriyasu F, Nada T, Suginoshita Y, Ito Y, Nishikawa K, et al. Influence of spontaneous portosystemic collateral pathways on portal hemodynamics in living-related liver transplantation in children. Transplantation 1995;60:41-45.
20. Yoshida EM, Erb SR, Ostrow DN, Ricci DR, Scudamore CH, Fradet G. Pulmonary hypertension associated with primary biliary cirrhosis in the absence portal hypertension: a case report. Gut 1994;35:280-282.
21. James WC, Peter NK, John LF, Ramona LD. High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 2002;122:1668-1673.
22. Van der Linden P, Le Moine O, Ghysels M, Ortinez M, Deviere J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 1996;23:982-987.
23. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991;100:520-528.
24. Takada Y, Ueda M, Ishikawa Y, Fujimoto Y, Miyauchi H, Ogura Y, et al. End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl 2004;10:807-810.
25. Rafanan AL, Maurer J, Mehta AC, Schilz R. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol. Chest 2000;118:1497-1500.